- Home
- UBX vs SMTK Comparison
UBX vs SMTK Comparison
Compare UBX & SMTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UBX
- SMTK
- Stock Information
- Founded
- UBX 2009
- SMTK 2009
- Country
- UBX United States
- SMTK United Kingdom
- Employees
- UBX N/A
- SMTK N/A
- Industry
- UBX Biotechnology: Pharmaceutical Preparations
- SMTK
- Sector
- UBX Health Care
- SMTK
- Exchange
- UBX Nasdaq
- SMTK NYSE
- Market Cap
- UBX 16.5M
- SMTK 13.3M
- IPO Year
- UBX 2018
- SMTK N/A
- Fundamental
- Price
- UBX $1.73
- SMTK $3.72
- Analyst Decision
- UBX Strong Buy
- SMTK
- Analyst Count
- UBX 2
- SMTK 0
- Target Price
- UBX $7.00
- SMTK N/A
- AVG Volume (30 Days)
- UBX 303.9K
- SMTK 109.9K
- Earning Date
- UBX 11-04-2024
- SMTK 02-12-2025
- Dividend Yield
- UBX N/A
- SMTK N/A
- EPS Growth
- UBX N/A
- SMTK N/A
- EPS
- UBX N/A
- SMTK N/A
- Revenue
- UBX N/A
- SMTK $40,000.00
- Revenue This Year
- UBX N/A
- SMTK N/A
- Revenue Next Year
- UBX $33.62
- SMTK N/A
- P/E Ratio
- UBX N/A
- SMTK N/A
- Revenue Growth
- UBX N/A
- SMTK 471.43
- 52 Week Low
- UBX $0.94
- SMTK $2.01
- 52 Week High
- UBX $2.02
- SMTK $13.00
- Technical
- Relative Strength Index (RSI)
- UBX 63.32
- SMTK N/A
- Support Level
- UBX $1.56
- SMTK N/A
- Resistance Level
- UBX $1.85
- SMTK N/A
- Average True Range (ATR)
- UBX 0.22
- SMTK 0.00
- MACD
- UBX 0.05
- SMTK 0.00
- Stochastic Oscillator
- UBX 75.96
- SMTK 0.00
About UBX Unity Biotechnology Inc.
Unity Biotechnology Inc designs therapeutics that prevent, halt, and reverse various diseases of aging. The company focuses on clearing senescent cells, and creating senolytic medicines. Its medicines target vulnerabilities unique to senescent cells to clear those cells from the human body while leaving normal cells unaffected. The firm focuses on age-associated diseases such as osteoarthritis, eye diseases, and pulmonary diseases. Its drug candidates include, UBX1325 is being developed for age-related diseases of the eye, including diabetic macular edema, or DME, UBX2089, which is a circulating hormone primarily produced in the kidneys and choroid plexus of the brain, which is being researched for multiple neurology indications, and UBX2050.
About SMTK SMARTKEM INC
SmartKem Inc focuses on the design, development, industrialization, and technology transfer of low-temperature, solution-deposited organic semiconductors for transistor backplanes. The company's semiconductor platform can be used in a number of applications including mini-LED displays, AMOLED displays, fingerprint sensors, and logic circuits. The company derives revenue from the sale of TRUFLEX inks and demonstration products.